This combination also establishes favorable co-stimulatory conditions that facilitate the differentiation of tumor-reactive CD8 T cells into an effector rather than an exhausted phenotype, thereby enhancing their anti-tumor activity (91). This evidence concerns the gene CD8A and neoplasm.